Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Panacea Biotec Ltd - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 This is with reference to CDSL's Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we are enclosing herewith the data of shares dematerialized during the month of September, 2019 as Annexure - 1. We would also like to confirm that the total number of shares dematerialized as on September 30, 2019, were as under: NSDL 57,232,111 CDSL 3,785,384 Total 61,017,495 A copy of the certificate obtained from the Company's RTA viz. Skyline Financial Services Pvt. Ltd., regarding shares dematerialized as on September 30, 2019 is also enclosed as Annexure - 2. This is for your information and record please. Kindly acknowledge the receipt.
07-10-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In continuation to our earlier communications dated May 30, 2019, May 31, 2019 and September 21, 2019 with respect to proposed Scheme of Arrangement between Panacea Biotec Limited and Ravinder Heights Limited and their respective shareholders and creditors pursuant to sections 230 to 232 & section 66 and other applicable provisions of the Companies Act, 2013, we would like to inform you that the Company along with Ravinder Heights Limited has filed joint first motion application for approval of the said Scheme of Arrangement before the Hon'ble National Company Law Tribunal, Chandigarh Bench ('NCLT') on Friday, i.e., September 27, 2019 to seek requisite directions. The aforesaid matter was listed before the Hon'ble NCLT on Friday, October 04, 2019. The Hon'ble NCLT heard the matter and has adjourned the same for further consideration on October 18, 2019. This is for your information and record.
05-10-2019
Bigul

Panacea Biotec Ltd - 531349 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Panacea Biotec Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
03-10-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Scrutinizer''s Report

 Please find enclosed herewith Scrutinizer''s Report.
01-10-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Details Of The Voting Results Pursuant To Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 This is in continuation of our earlier letter dated October 01, 2019 informing that the detailed results of remote e-voting and the poll conducted at the 35th Annual General Meeting ('AGM') of the Company held on September 30, 2019, as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations') shall be forwarded to you on the receipt of Scrutinizer's Report. We would like to inform you that all the resolutions mentioned in the AGM notice have been passed by shareholders with requisite majority. Pursuant to Regulation 44(3) of the SEBI LODR Regulations read with amended Rule 20 of Companies (Management and Administration) Rules, 2015, the combined results of remote e-voting and poll conducted at the AGM along with the Scrutinizer's Report is enclosed herewith.
01-10-2019
Bigul

Panacea Biotec Ltd - 531349 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Pursuant to the provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), please find enclosed herewith the proceedings of the 35th Annual General Meeting ('AGM') of the Company held on September 30, 2019, at the registered office of the Company at Ambala-Chandigarh Highway, Lalru - 140501, Punjab. Further, the detailed results of remote e-voting and the poll conducted at the AGM on all the businesses as set out in the Notice, as required under Regulation 44 of the SEBI LODR Regulations shall be forwarded to you on the receipt of Scrutinizer's Report. This is for your information and record please.
01-10-2019
Bigul

Panacea Biotec Ltd - 531349 - Closure of Trading Window

 Pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons of the Company and Material Subsidiaries of the Company from October 01, 2019 till completion of 48 hours from the announcement to the Stock Exchanges of the Unaudited financial results of the Company for the quarter ending September 30, 2019. The date of meeting of the Board of Directors to approve the Unaudited financial results of the Company for the quarter ending September 30, 2019 will be informed in due course.
28-09-2019
Bigul

Panacea Biotec Ltd - 531349 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In continuation to our earlier communications dated May 30, 2019 and May 31, 2019, we would like to inform you that BSE Limited and National Stock Exchange of India Limited have issued letters dated September 19, 2019 and September 20, 2019 respectively with no adverse observations on our application filed under Regulation 37 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the draft Scheme of Arrangement between Panacea Biotec Limited and Ravinder Heights Limited and their respective shareholders and creditors pursuant to Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, subject to approval of National Company Law Tribunal (NCLT). A copy each of the above said Observation Letters is enclosed herewith for reference. The said Observation Letters are also available on the website of the Company and can be accessed at https://www.panaceabiotec.com/scheme-of-arrangement.
21-09-2019
Bigul

Panacea Biotec Ltd - 531349 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Panacea Biotec Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
12-09-2019
Bigul

Panacea Biotec Ltd - 531349 - Scrutinizer''s Report

 Please find attached herewith Scrutinizer''s Report.
11-09-2019
Next Page
Close

Let's Open Free Demat Account